Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Ton

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Biotechnology and Bioengineering|July 12, 2024
Development and qualification of 3 L scale-down model for large scale vaccine process on Vero cell culture using microcarriersRenjing Huang, Kai Wang, Matthew H Flamm, et al.
Biotechnology and Bioengineering|May 14, 2025
CRISPR-Editing of the Vero Cell Line Improves Processability of Live Virus Vaccines by Enabling Targeted Proteolysis of FibronectinJackson K B Cahn, Henry Ludwicki, Jillian Shingler, et al.
PDA Journal of Pharmaceutical Science and Technology|June 7, 2015
Microbial Monitoring For Biological Drug Substance Manufacturing: An Industry PerspectiveDavid Bain, Diane Hardy, Brian L Bell, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Biotechnology and Bioengineering|July 12, 2024
Development and qualification of 3 L scale-down model for large scale vaccine process on Vero cell culture using microcarriersRenjing Huang, Kai Wang, Matthew H Flamm, et al.
Biotechnology and Bioengineering|May 14, 2025
CRISPR-Editing of the Vero Cell Line Improves Processability of Live Virus Vaccines by Enabling Targeted Proteolysis of FibronectinJackson K B Cahn, Henry Ludwicki, Jillian Shingler, et al.
PDA Journal of Pharmaceutical Science and Technology|June 7, 2015
Microbial Monitoring For Biological Drug Substance Manufacturing: An Industry PerspectiveDavid Bain, Diane Hardy, Brian L Bell, et al.
Pageof 2